Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.72 |
| ▸ | FNTB | P49356 | 5/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.61 |
| ▸ | SQLE | Q14534 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10750568 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL30173637 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL2573231 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL29595985 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL1395165 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL5080365 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL20435504 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL1952603 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL31652308 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL458219 | 1.00 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025202181-A1 | TERPENOID COMPOSITIONS AND BLENDS THEREOF | EVODIABIO APS (DK) | 2025-10-02 | — | — | WO | claimed |
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| WO-2023222753-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| US-10434485-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2019-10-08 | — | — | US | claimed |
| US-9878299-B2 | Methods for encapsulation of actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-30 | — | — | US | claimed |
| US-20170296996-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | PROCTER & GAMBLE (US) | 2017-10-19 | — | — | US | claimed |
| US-9718044-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-01 | — | — | US | claimed |
| US-20160144330-A1 | Methods for Encapsulation of Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| US-20160145535-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| EP-2134377-B1 | FRAGRANCE DISPENSER | SYMRISE AG (DE) | 2012-07-18 | — | — | EP | claimed |
| US-8191796-B2 | Fragrance dispenser | SYMRISE AG (DE) | 2012-06-05 | — | — | US | claimed |
| US-20100287710-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-11-18 | — | — | US | claimed |
| US-20100056422-A1 | FRAGRANCE DISPENSER | SYMRISE GMBH & CO. KG (DE) | 2010-03-04 | — | — | US | claimed |
| EP-2134377-A1 | FRAGRANCE DISPENSER | Symrise GmbH & Co. KG (DE) | 2009-12-23 | — | — | EP | claimed |
| WO-2008104226-A1 | FRAGRANCE DISPENSER | SYMRISE GMBH & CO. KG (DE) | 2008-09-04 | — | — | WO | claimed |
| US-12612577-B2 | Perfumed compositions, process of preparing thereof and uses | MINASOLVE SAS (FR) | 2026-04-28 | — | — | US | disclosed |
| US-5157027-A | Anticholesterol agents | E. R. SQUIBB & SONS, INC. (US) | 1992-10-20 | — | — | US | disclosed |
| US-4025539-A | Process for preparing 2-substituted or unsubstituted geranyl acetic acids and esters thereof | KURARAY CO., LTD. (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612577-B2 | Perfumed compositions, process of preparing thereof and uses | DEGS1, C5, POLE3 | FNTA 2939/4885FNTB 1825/4885KMT2A 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.